| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Lisa McClain MI09 | 3 | 3 | +$0 | Sold Oct 31, 25 |
| Rob Bresnahan PA08 | 1 | +$8.0K | Bought May 15, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Oct 31, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (21d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Sep 25, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Oct 22, 25 (27d) | |
| Aug 4, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Sep 12, 25 (39d) | |
| Jul 22, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (22d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | Jun 9, 25 (25d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 31, 2026 | Zielinski Anita A.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 13.4K | — |
| May 4, 2026 | Shafer David BrentChairman of the Board | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Mcdonnell Michael RDirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Wilkes David S. M.D.Director | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Ampofo William A. IiDirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Wendell Amy McbrideDirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Schlichting Nancy MDirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Morrison Patricia BDirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| May 4, 2026 | Craig Jeffrey ADirector | Stock Award(Grant) at price 0.00 per share. | 12.8K | — |
| Feb 26, 2026 | Zielinski Anita A.Officer | Stock Award(Grant) at price 0.00 per share. | 30.9K | — |
| Feb 26, 2026 | Rosenbloom David SGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 26.7K | — |
| Feb 26, 2026 | Hider Andrew PChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 201.8K | — |
| Feb 26, 2026 | Carlisle CynthiaOfficer | Stock Award(Grant) at price 0.00 per share. | 29.7K | — |
| Feb 26, 2026 | Soriano Maria CeciliaOfficer | Stock Award(Grant) at price 0.00 per share. | 23.7K | — |
| Feb 26, 2026 | Grade Joel T.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 42.7K | — |
| Feb 12, 2026 | Mcdonnell Michael RDirector | Stock Award(Grant) at price 0.00 per share. | 1.8K | — |
| Feb 8, 2026 | Rosenbloom David SGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 17.1K | — |
| Feb 8, 2026 | Rasul ReazurOfficer | Stock Award(Grant) at price 0.00 per share. | 19K | — |
| Feb 8, 2026 | Soriano Maria CeciliaOfficer | Stock Award(Grant) at price 0.00 per share. | 2.3K | — |
| Feb 8, 2026 | Grade Joel T.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Buy / hold / sell counts
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.0 | 1.5 | -17.5 | 4.6 | 6.8 | 13.5 | 22.7 | -0.6 | -7.7 | 3.3 | +29.7% | ||
| 2025 | 11.7 | 6.0 | -0.8 | -8.9 | -2.1 | -0.7 | -28.1 | 13.5 | -7.8 | -18.9 | 1.5 | 2.0 | −34.5% |
| 2024 | 0.1 | 5.8 | 4.4 | -5.5 | -15.6 | -1.9 | 7.1 | 5.9 | 0.1 | -6.0 | -5.6 | -13.5 | −24.6% |
| 2023 | -10.4 | -12.6 | 1.5 | 17.6 | -14.6 | 11.9 | -0.7 | -10.2 | -7.0 | -14.1 | 11.3 | 7.2 | −24.2% |
| 2022 | -0.5 | -0.6 | -8.7 | -8.4 | 7.0 | -15.5 | -8.7 | -2.0 | -6.3 | 0.9 | 4.0 | -9.8 | −40.6% |
| 2021 | -4.2 | 1.1 | 8.6 | 1.6 | -4.2 | -2.0 | -3.9 | -1.5 | 5.5 | -1.8 | -5.6 | 15.1 | +7.0% |
| 2020 | 6.7 | -6.4 | -2.7 | 9.3 | 1.4 | -4.3 | 0.3 | 0.8 | -7.6 | -3.5 | -1.9 | 5.5 | −4.0% |
| 2019 | 10.1 | 3.1 | 8.8 | -6.2 | -3.7 | 11.5 | 2.5 | 4.7 | -0.5 | -12.3 | 6.9 | 2.0 | +27.0% |
| 2018 | 11.4 | -5.9 | -4.1 | 6.9 | 1.9 | 4.2 | -1.9 | 2.7 | 3.7 | -18.9 | 9.7 | -4.0 | +1.8% |
| 2017 | 8.1 | 6.3 | 1.8 | 7.4 | 6.5 | 2.1 | -0.1 | 2.6 | 1.1 | 2.7 | 1.6 | -1.4 | +45.8% |
| 2016 | -4.1 | 8.0 | 4.0 | 7.6 | -2.4 | 4.8 | 6.2 | -2.7 | 1.9 | -0.0 | -6.8 | -0.1 | +16.2% |
| 2015 | -4.1 | -1.6 | -0.9 | 0.4 | -3.1 | 5.0 | 5.5 | -4.1 | -14.6 | 13.8 | 0.7 | 1.3 | −4.2% |
| 2014 | -1.8 | 1.8 | 5.9 | -1.1 | 2.2 | -2.8 | 3.3 | 0.4 | -4.3 | -2.3 | 4.1 | 0.4 | +5.4% |
| 2013 | 1.8 | -0.4 | 7.5 | -3.8 | 0.7 | -1.5 | 5.4 | -4.8 | -5.6 | 0.3 | 3.9 | 1.6 | +4.3% |
| 2012 | 12.1 | 4.8 | 2.8 | -7.3 | -8.6 | 5.0 | 10.1 | 0.3 | 2.7 | 3.9 | 5.8 | 0.6 | +34.7% |
| 2011 | -4.2 | 9.6 | 1.2 | 5.8 | 4.6 | 0.3 | -2.5 | -3.8 | 0.3 | -2.1 | -6.0 | -4.2 | −2.3% |
| 2010 | -1.9 | -1.1 | 2.2 | -18.9 | -10.6 | -3.8 | 7.7 | -2.8 | 12.1 | 6.7 | -4.7 | 4.3 | −13.7% |
| 2009 | 9.4 | -13.2 | 0.6 | -5.3 | 5.5 | 3.5 | 6.4 | 1.0 | 0.2 | -5.2 | 0.9 | 7.6 | +9.5% |
| 2008 | 4.3 | -2.5 | -2.0 | 7.8 | -2.0 | 4.6 | 7.3 | -1.2 | -3.1 | -7.8 | -12.5 | 1.3 | −7.7% |
| 2007 | 7.0 | 0.7 | 5.3 | 7.5 | 0.4 | -0.9 | -6.6 | 4.1 | 2.8 | 6.6 | -0.2 | -3.0 | +25.1% |